Cargando…

Health‐related quality of life around the time of diagnosis in patients with bladder cancer

OBJECTIVES: To quantify the health‐related quality of life (HRQoL) of patients with bladder cancer around the time of diagnosis and to test the hypotheses of a two‐factor model for the HRQoL questionnaire QLQ‐C30. METHODS: From participants in the Bladder Cancer Prognoses Programme, a multicentre co...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Evan Yi‐Wen, Nekeman, Duncan, Billingham, Lucinda J., James, Nicholas D., Cheng, KK, Bryan, Richard T., Wesselius, Anke, Zeegers, Maurice P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907410/
https://www.ncbi.nlm.nih.gov/pubmed/31077532
http://dx.doi.org/10.1111/bju.14804
_version_ 1783478533127929856
author Yu, Evan Yi‐Wen
Nekeman, Duncan
Billingham, Lucinda J.
James, Nicholas D.
Cheng, KK
Bryan, Richard T.
Wesselius, Anke
Zeegers, Maurice P.
author_facet Yu, Evan Yi‐Wen
Nekeman, Duncan
Billingham, Lucinda J.
James, Nicholas D.
Cheng, KK
Bryan, Richard T.
Wesselius, Anke
Zeegers, Maurice P.
author_sort Yu, Evan Yi‐Wen
collection PubMed
description OBJECTIVES: To quantify the health‐related quality of life (HRQoL) of patients with bladder cancer around the time of diagnosis and to test the hypotheses of a two‐factor model for the HRQoL questionnaire QLQ‐C30. METHODS: From participants in the Bladder Cancer Prognoses Programme, a multicentre cohort study, sociodemographic data were collected using semi‐structured face‐to‐face interviews. Answers to the QLQ‐C30 were transformed into a scale from 0 to 100. HRQoL data were analysed in multivariate analyses. The hypothesized two‐factor (Physical and Mental Health) domain structure of the QLQ‐C30 was also tested with confirmatory factor analyses (CFA). RESULTS: A total of 1160 participants (78%) completed the questionnaire after initial visual diagnosis and before pathological confirmation. Despite non‐muscle‐invasive bladder cancer (NMIBC) being associated with a higher HRQoL than carcinoma invading bladder muscle, only the domain Role Functioning was clinically significantly better in patients with NMIBC. Age, gender, bladder cancer stage and comorbidity all had a significant influence on QLQ‐C30 scores. The CFA showed an overall good fit of the hypothesized two‐factor model. CONCLUSION: This study identified a baseline reference value for HRQoL for patients with bladder cancer, which allows better evaluation of any changes in HRQoL as disease progresses or after treatment. In addition, a two‐factor (Physical and Mental Health) model was developed for the QLQ‐C30.
format Online
Article
Text
id pubmed-6907410
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69074102019-12-23 Health‐related quality of life around the time of diagnosis in patients with bladder cancer Yu, Evan Yi‐Wen Nekeman, Duncan Billingham, Lucinda J. James, Nicholas D. Cheng, KK Bryan, Richard T. Wesselius, Anke Zeegers, Maurice P. BJU Int Urological Oncology OBJECTIVES: To quantify the health‐related quality of life (HRQoL) of patients with bladder cancer around the time of diagnosis and to test the hypotheses of a two‐factor model for the HRQoL questionnaire QLQ‐C30. METHODS: From participants in the Bladder Cancer Prognoses Programme, a multicentre cohort study, sociodemographic data were collected using semi‐structured face‐to‐face interviews. Answers to the QLQ‐C30 were transformed into a scale from 0 to 100. HRQoL data were analysed in multivariate analyses. The hypothesized two‐factor (Physical and Mental Health) domain structure of the QLQ‐C30 was also tested with confirmatory factor analyses (CFA). RESULTS: A total of 1160 participants (78%) completed the questionnaire after initial visual diagnosis and before pathological confirmation. Despite non‐muscle‐invasive bladder cancer (NMIBC) being associated with a higher HRQoL than carcinoma invading bladder muscle, only the domain Role Functioning was clinically significantly better in patients with NMIBC. Age, gender, bladder cancer stage and comorbidity all had a significant influence on QLQ‐C30 scores. The CFA showed an overall good fit of the hypothesized two‐factor model. CONCLUSION: This study identified a baseline reference value for HRQoL for patients with bladder cancer, which allows better evaluation of any changes in HRQoL as disease progresses or after treatment. In addition, a two‐factor (Physical and Mental Health) model was developed for the QLQ‐C30. John Wiley and Sons Inc. 2019-06-07 2019-12 /pmc/articles/PMC6907410/ /pubmed/31077532 http://dx.doi.org/10.1111/bju.14804 Text en © 2019 The Authors BJU International Published by John Wiley & Sons Ltd on behalf of BJU International This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Urological Oncology
Yu, Evan Yi‐Wen
Nekeman, Duncan
Billingham, Lucinda J.
James, Nicholas D.
Cheng, KK
Bryan, Richard T.
Wesselius, Anke
Zeegers, Maurice P.
Health‐related quality of life around the time of diagnosis in patients with bladder cancer
title Health‐related quality of life around the time of diagnosis in patients with bladder cancer
title_full Health‐related quality of life around the time of diagnosis in patients with bladder cancer
title_fullStr Health‐related quality of life around the time of diagnosis in patients with bladder cancer
title_full_unstemmed Health‐related quality of life around the time of diagnosis in patients with bladder cancer
title_short Health‐related quality of life around the time of diagnosis in patients with bladder cancer
title_sort health‐related quality of life around the time of diagnosis in patients with bladder cancer
topic Urological Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907410/
https://www.ncbi.nlm.nih.gov/pubmed/31077532
http://dx.doi.org/10.1111/bju.14804
work_keys_str_mv AT yuevanyiwen healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer
AT nekemanduncan healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer
AT billinghamlucindaj healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer
AT jamesnicholasd healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer
AT chengkk healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer
AT bryanrichardt healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer
AT wesseliusanke healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer
AT zeegersmauricep healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer